HQ Capital is an independent alternative investment manager headquartered in New York, with additional offices in Europe and Asia. Founded in 1989 and formally established as a brand in 2015 through the merger of several investment firms, it specializes in private equity and real estate, managing over $12 billion in assets. The firm engages in direct co-investments, fund of funds investments, and secondary investments, focusing on various sectors, including retail and healthcare. It typically invests between $10 million and $50 million in private equity transactions and seeks majority stakes in small to mid-sized companies. HQ Capital is dedicated to aligning its interests with those of its clients, utilizing a business model that emphasizes significant financial contributions from its senior team. With a global presence and more than 25 years of experience, HQ Capital aims to deliver tailored investment solutions that generate long-term attractive returns.
Interlace Medical, Inc. specializes in the design and development of medical devices aimed at interventional gynecologists for office-based procedures. The company focuses on treating gynecological diseases and conditions that have traditionally required surgical intervention in an operating room setting. Among its notable products is the MyoSure hysteroscopic tissue removal system, which is specifically designed for the removal of submucosal fibroids and polyps. Through its innovative solutions, Interlace Medical seeks to enhance the efficiency and effectiveness of gynecological treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.